Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response
Publication
, Conference
Keystone, E; Van der Heijde, D; Smolen, J; Weinblatt, M; Kvien, T; Strand, V; Ansari, Z; Goel, N; Combe, B
Published in: JOURNAL OF RHEUMATOLOGY
June 1, 2010
Duke Scholars
Published In
JOURNAL OF RHEUMATOLOGY
ISSN
0315-162X
Publication Date
June 1, 2010
Volume
37
Issue
6
Start / End Page
1333 / 1333
Location
Quebec, CANADA
Publisher
J RHEUMATOL PUBL CO
Conference Name
65th Annual Meeting of the Canadian-Rheumatology-Association
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keystone, E., Van der Heijde, D., Smolen, J., Weinblatt, M., Kvien, T., Strand, V., … Combe, B. (2010). Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response. In JOURNAL OF RHEUMATOLOGY (Vol. 37, pp. 1333–1333). Quebec, CANADA: J RHEUMATOL PUBL CO.
Keystone, Edward, Desiree Van der Heijde, Joseph Smolen, Michael Weinblatt, Tore Kvien, Vibeke Strand, Zainab Ansari, Niti Goel, and Bernard Combe. “Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response.” In JOURNAL OF RHEUMATOLOGY, 37:1333–1333. J RHEUMATOL PUBL CO, 2010.
Keystone E, Van der Heijde D, Smolen J, Weinblatt M, Kvien T, Strand V, et al. Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response. In: JOURNAL OF RHEUMATOLOGY. J RHEUMATOL PUBL CO; 2010. p. 1333–1333.
Keystone, Edward, et al. “Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response.” JOURNAL OF RHEUMATOLOGY, vol. 37, no. 6, J RHEUMATOL PUBL CO, 2010, pp. 1333–1333.
Keystone E, Van der Heijde D, Smolen J, Weinblatt M, Kvien T, Strand V, Ansari Z, Goel N, Combe B. Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response. JOURNAL OF RHEUMATOLOGY. J RHEUMATOL PUBL CO; 2010. p. 1333–1333.
Published In
JOURNAL OF RHEUMATOLOGY
ISSN
0315-162X
Publication Date
June 1, 2010
Volume
37
Issue
6
Start / End Page
1333 / 1333
Location
Quebec, CANADA
Publisher
J RHEUMATOL PUBL CO
Conference Name
65th Annual Meeting of the Canadian-Rheumatology-Association
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences